IB
Immage Biotherapeutics Corp. Stock: price and insider trades · United States
Immage Biotherapeutics Corp.: what insiders have been doing
Immage Biotherapeutics Corp. has a thin disclosure history in our data (latest filing: 10 November 2015). New filings will appear here as soon as they are published. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Financial data
· cache
US$0.00
Analyst consensus
Income statement
EBITDA-US$1.8M
Valuation
Beta51.35
Balance sheet & cash
Debt / Equity252%
Profitability & ownership
ROE-1133.6%
ROA-496.1%
% insiders69.9%
% institutions0.0%
Last declaration on 10 November 2015
Declarations1 total
- 42,943,521 shares0Common StockSEC:0001646136-15-000002:0
1 of 1 declaration
About Immage Biotherapeutics Corp.
Immage Biotherapeutics Corp. is a company focused on the development of biopharmaceutical therapies. It is listed on the XNAS market.
